NHS England

NHS Framework for the Midlands and East, Branded Medicines - Tranche A plus Cytokine Modulators and other Monoclonal Antibodies. Offer reference number: CM/PHR/16/5525 CM/PHR/16/55

NHS National Pharmaceuticals Transition 2019_2 Offer reference number: CM/PHG/17/5548 Period of framework agreement: The total maximum duration of the framework agreement to be no

Lanadelumab

This Notice solely relates to early market engagement around the development of a CGM in T1 Pregnancy programme, which aims to offer CGM to pregnant women living with type 1 diabet

NHS framework agreement to supply aseptically prepared cytotoxic medicines and monoclonal antibodies - East of England, London and South East Coast. The framework may also be used

The National Ambulance Resilience Unit's (NARU) main aim is to support the emergency preparedness, resilience and response (EPRR) objectives of NHS England. NARU works on behalf of

NHS National Framework Agreement for Pharmaceuticals - Transition 2019_2. Regions: Central and South West (CESW); North West and Eastern and North London (NWLN); and South East and

Aseptically Prepared Cytotoxic Medicines & Monoclonal Antibodies - East of England, London and South East Coast

NHS Framework Agreement for Branded Medicines - National Contract Period: 1 May 2019 to 30 April 2021 (with an option to extend for a period or periods of up 24 months) Tender Refe

National Agreement for the supply of Teriparatide (Interim Agreement) Offer reference number: CM/PHR/19/5578/01 & CM/PHR/19/5578/02 Period of framework agreement: CM/PHR/19/5578/01

Framework agreement for NHS National Generic Pharmaceuticals - Interim Offer reference number: CM/PHG/18/5574 Period of framework agreement: Dates detailed below with options to ex

NHS Long Term Plan sets out the ambition that Integrated Care Systems (ICSs) will eventually cover all of the country, making shared decisions with providers on how to use resource

OJEU tender for replacement contracts for the Time for Care programme - Productive General Practice Quick Start programme. Additional information: Delivery Partners (DP's) were sou

Every patient journey to NHS specialist dental care should begin with a visit to his or her primary dental care practitioner from whom they receive regular care. This dentist may w

NHS National framework agreement for the supply of the home parenteral nutrition & intravenous fluid for patients with severe intestinal failure 1 April 2020 to 31 March 2022 with

Calling of the single supplier Lot 1 of the CCS framework agreement RM3785 for managed print and distribution requirements.

NHS National framework agreement for the supply of the home parenteral nutrition & intravenous fluid for patients with severe intestinal failure 1 April 2020 to 31 March 2022 with

NHS National framework agreement for the supply of the home Parenteral nutrition & intravenous fluid for patients with severe intestinal failure Offer Reference number: CM/MSR/17/5

This Notice solely relates to early market engagement around the development of a Low Calorie Diets (LCD) programme, which will aim to pilot optimal implementation models for progr

The required Service is the delivery of the Children and Young People's Cancer Patient Experience Survey on behalf of NHS England. This will include: - Supporting completion of sur